Pharma Journalist -

GenScript announced the launch of its Research Lentiviral Vector Packaging Service for cell line development, gene editing, and drug discovery. The service enables scientists to package…
Read More...

SMi Group Reports: There is less than two weeks remaining until the highly anticipated 21st Annual Pain Therapeutics Virtual Conference, on 10th and 11th May 2021. SMi Group are…
Read More...

LogicBio Therapeutics, Inc. a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through…
Read More...

Merck known as MSD outside the United States and Canada, announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established…
Read More...

Geneseeq Technology Inc. and AstraZeneca are excited to announce their strategic collaboration to establish a Bio-Diagnostic Innovation Center in Guangzhou, China. The center is…
Read More...

ProBioGen AG announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at…
Read More...

Mirum Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application No. 16/994,368. The…
Read More...

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.…
Read More...

AstraZeneca and MSD’s selumetinib has been recommended for conditional marketing authorisation in the European Union (EU) for the treatment of symptomatic, inoperable plexiform…
Read More...

Pieris Pharmaceuticals, Inc. and Boston Pharmaceuticals announced that the companies have entered into an exclusive product license agreement to develop PRS-342, a 4-1BB/GPC3…
Read More...